Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer☆

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer☆
Authors
Keywords
Cost-effectiveness, Immunotherapy, PD-1, Head and neck cancer, Markov model
Journal
ORAL ONCOLOGY
Volume 74, Issue -, Pages 49-55
Publisher
Elsevier BV
Online
2017-09-23
DOI
10.1016/j.oraloncology.2017.09.017

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.